High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)
Clinical trial NCT01936831 · COMPLETED
Trial details
- NCT number
- NCT01936831
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-13
- Primary completion
- 2021-09-22
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.